NYU LANGONE HEALTH
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1841-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.nyulangone.org
Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Brain Cancer
- Conditions
- Brain and Central Nervous System Tumors
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00025558
- Locations
- 🇦🇺
Princess Margaret Hospital for Children, Perth, Western Australia, Australia
🇺🇸NYU Cancer Institute at New York University Medical Center, New York, New York, United States
🇺🇸Columbus Children's Hospital, Columbus, Ohio, United States
Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2011-03-28
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 36
- Registration Number
- NCT00003332
- Locations
- 🇺🇸
NYU School of Medicine's Kaplan Comprehensive Cancer Center, New York, New York, United States
Combination Chemotherapy in Treating Patients With Advanced Ovarian Epithelial Cancer
- Conditions
- Ovarian Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2012-11-09
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00005051
- Locations
- 🇺🇸
University of Wisconsin Comprehensive Cancer Center, Madison, Wisconsin, United States
🇺🇸Saint Vincent Catholic Medical Center of New York, New York, New York, United States
🇺🇸New York Hospital Medical Center of Queens, Fresh Meadows, New York, United States
Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Brain Tumor
- Conditions
- RetinoblastomaBrain and Central Nervous System TumorsNeuroblastomaSarcoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00003273
- Locations
- 🇺🇸
Cancer Research Center of Hawaii, Honolulu, Hawaii, United States
🇺🇸State University of New York Health Sciences Center - Stony Brook, Stony Brook, New York, United States
🇺🇸Maine Children's Cancer Program, Scarborough, Maine, United States
Occupation and Asthma in an Urban Low Income Population
- Conditions
- AsthmaLung Diseases
- First Posted Date
- 2001-04-12
- Last Posted Date
- 2015-12-18
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 800
- Registration Number
- NCT00014820
Dexamethasone Treatment for Congenital Heart Block (CHB) in Newborns With Lupus
- Conditions
- Congenital Heart BlockNeonatal LupusAtrioventricular Nodal DysfunctionMyocardial Injury
- Interventions
- First Posted Date
- 2000-12-18
- Last Posted Date
- 2016-03-11
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 150
- Registration Number
- NCT00007358
- Locations
- 🇺🇸
New York University Medical Center, New York, New York, United States
🇺🇸St. Barnabas Medical Center, Livingston, New Jersey, United States
🇺🇸Hospital for Joint Diseases, New York, New York, United States
Tuberculosis in a Multiethnic Inner City Population
- Conditions
- Lung DiseasesAcquired Immunodeficiency SyndromeTuberculosisHIV InfectionsMycobacterium Tuberculosis
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2015-12-29
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00005379
Intermittent ST Depression and Prognosis After Myocardial Infarction
- Conditions
- Heart DiseasesCardiovascular DiseasesMyocardial Infarction
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2016-01-28
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00005217
Endogenous Estrogen and Coronary Heart Disease in Women
- Conditions
- Heart DiseasesMyocardial InfarctionPostmenopauseCardiovascular DiseasesCoronary Disease
- First Posted Date
- 2000-05-26
- Last Posted Date
- 2015-12-31
- Lead Sponsor
- NYU Langone Health
- Registration Number
- NCT00005446
Occluded Artery Trial (OAT)
- Conditions
- Myocardial InfarctionHeart FailureHeart Failure, CongestiveCardiovascular DiseasesHeart Diseases
- Interventions
- Drug: Beta adrenergic blockersDrug: Platelet inhibitorsProcedure: PTCA and stentsDrug: ACE Inhibitors
- First Posted Date
- 2000-02-10
- Last Posted Date
- 2014-04-21
- Lead Sponsor
- NYU Langone Health
- Target Recruit Count
- 2201
- Registration Number
- NCT00004562
- Locations
- 🇺🇸
New York University School of Medicine, New York, New York, United States